Top 10 Biotech Stocks with Highest Return on Equity: GTXI, OSIR, TLCR, GILD, CHBT, SCLN, PSDV, WX, SKBI, TECH (Nov 30, 2010)

Below are the top 10 Biotechnology stocks with highest Return on Equity (ROE)
ratio for the last 12 months, UPDATED TODAY before 4:30 AM ET. ROE shows a
companys efficiency in making profits from shareholders equity. It is equal to
net profits divided by shareholders equity. Three Chinese companies (CHBT, WX,
SKBI) are on the list. GTx, Inc. (NASDAQ:GTXI) has the 1st highest Return on
Equity in this segment of the market. Its ROE was 132.69% for the last 12
months. Its net profit margin was 19.12% for the same period. Osiris
Therapeutics, Inc. (NASDAQ:OSIR) has the 2nd highest Return on Equity in this
segment of the market. Its ROE was 87.23% for the last 12 months. Its net profit
margin was 19.56% for the same period. Talecris Biotherapeutics Holdings Corp
(NASDAQ:TLCR) has the 3rd highest Return on Equity in this segment of the
market. Its ROE was 76.35% for the last 12 months. Its net profit margin was
19.00% for the same period. Gilead Sciences, Inc. (NASDAQ:GILD) has the 4th
highest Return on Equity in this segment of the market. Its ROE was 54.15% for
the last 12 months. Its net profit margin was 38.37% for the same period.
China-Biotics Inc. (NASDAQ:CHBT) has the 5th highest Return on Equity in this
segment of the market. Its ROE was 34.03% for the last 12 months. Its net profit
margin was 44.24% for the same period. SciClone Pharmaceuticals, Inc.
(NASDAQ:SCLN) has the 6th highest Return on Equity in this segment of the
market. Its ROE was 29.97% for the last 12 months. Its net profit margin was
24.80% for the same period. pSivida Corp. (NASDAQ:PSDV) has the 7th highest
Return on Equity in this segment of the market. Its ROE was 27.47% for the last
12 months. Its net profit margin was 35.92% for the same period. WuXi PharmaTech
(Cayman) Inc. (ADR) (NYSE:WX) has the 8th highest Return on Equity in this
segment of the market. Its ROE was 27.22% for the last 12 months. Its net profit
margin was 26.94% for the same period. Skystar Bio-Pharmaceutical Company
(NASDAQ:SKBI) has the 9th highest Return on Equity in this segment of the
market. Its ROE was 26.77% for the last 12 months. Its net profit margin was
30.88% for the same period. Techne Corporation (NASDAQ:TECH) has the 10th
highest Return on Equity in this segment of the market. Its ROE was 21.99% for
the last 12 months. Its net profit margin was 40.44% for the same period.